OMERS Administration Corp’s Century Therapeutics IPSC Stock Holding History

OMERS Administration Corp’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$108K	Buy	+47,800	New	+$101K	﹤0.01%	1007

Other funds holding IPSC

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

OMERS Administration Corp's IPSC Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Century Therapeutics (IPSC) in Q1 2026: 47,800 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1007 among its holdings.

72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

OMERS Administration Corp held 47,800 shares of Century Therapeutics worth $108K as of Q1 2026.
Century Therapeutics was a new OMERS Administration Corp position in Q1 2026.
Century Therapeutics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #1007 holding.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.